论文部分内容阅读
运用酶联免疫分析法检测613例肝病患者血清抗-HCV,阳性53例(8.65％)。对其中资料完整的293例病人血清抗-HCV进行了分类统计,显示乙型肝炎病毒感染标志(HBVM)阳性及阴性病人的抗-HCV阳性率分别为9.86％及8.75％,两者比较无显著差异(P>0.05)。肝硬变患者抗-HCV的阳性率为7.1％。
Serum anti-HCV was detected in 613 patients with liver disease by enzyme-linked immunosorbent assay (53 cases, 8.6%). The classification of anti-HCV in 293 patients with complete data showed that the positive rates of anti-HCV in HBVM-positive and -negative patients were 9.86% and 8.75%, respectively, with no significant difference between the two Difference (P> 0.05). The positive rate of anti-HCV in patients with cirrhosis was 7.1%.